Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.808
-0.041 (-4.85%)
Apr 29, 2026, 12:48 PM EDT - Market open
Vivos Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 2.03 | 6.26 | 1.64 | 3.52 | 24.03 | Upgrade
|
| Cash & Short-Term Investments | 2.03 | 6.26 | 1.64 | 3.52 | 24.03 | Upgrade
|
| Cash Growth | -67.59% | 281.01% | -53.31% | -85.36% | 31.99% | Upgrade
|
| Accounts Receivable | 1.58 | 0.43 | 0.2 | 0.46 | 1.72 | Upgrade
|
| Receivables | 1.58 | 0.43 | 0.2 | 0.46 | 1.72 | Upgrade
|
| Prepaid Expenses | 0.77 | 0.78 | 0.62 | 1.45 | 1.58 | Upgrade
|
| Total Current Assets | 4.38 | 7.47 | 2.46 | 5.42 | 27.32 | Upgrade
|
| Property, Plant & Equipment | 7.92 | 4.34 | 4.7 | 4.78 | 2.83 | Upgrade
|
| Goodwill | 8.57 | 2.84 | 2.84 | 2.84 | 2.84 | Upgrade
|
| Other Intangible Assets | 4.05 | 0.41 | 0.42 | 0.3 | 0.34 | Upgrade
|
| Other Long-Term Assets | 0.23 | 0.22 | 0.31 | 0.37 | 0.36 | Upgrade
|
| Total Assets | 25.15 | 15.28 | 10.73 | 13.72 | 33.69 | Upgrade
|
| Accounts Payable | 1.68 | 1.1 | 2.15 | 1.41 | 0.92 | Upgrade
|
| Accrued Expenses | 5.99 | 2.23 | 2.33 | 1.91 | 2.85 | Upgrade
|
| Current Portion of Long-Term Debt | 8.35 | - | - | - | 1.27 | Upgrade
|
| Current Portion of Leases | 0.73 | 0.48 | 0.47 | 0.42 | - | Upgrade
|
| Current Unearned Revenue | 0.48 | 0.9 | 2.14 | 2.93 | 2.4 | Upgrade
|
| Other Current Liabilities | 0.85 | 0.27 | 0.2 | 0.15 | 0.07 | Upgrade
|
| Total Current Liabilities | 18.08 | 4.98 | 7.29 | 6.81 | 7.51 | Upgrade
|
| Long-Term Debt | 0.47 | - | - | - | - | Upgrade
|
| Long-Term Leases | 3.95 | 1.04 | 1.52 | 1.99 | - | Upgrade
|
| Long-Term Unearned Revenue | - | 0.1 | 0.29 | 0.11 | - | Upgrade
|
| Other Long-Term Liabilities | 4.2 | 1.22 | 1.22 | - | 0.64 | Upgrade
|
| Total Liabilities | 26.7 | 7.33 | 10.32 | 8.92 | 8.15 | Upgrade
|
| Common Stock | 0 | - | - | - | 0 | Upgrade
|
| Additional Paid-In Capital | 123.87 | 112.14 | 93.46 | 84.27 | 81.16 | Upgrade
|
| Retained Earnings | -125.36 | -104.19 | -93.05 | -79.47 | -55.62 | Upgrade
|
| Total Common Equity | -1.49 | 7.95 | 0.41 | 4.8 | 25.54 | Upgrade
|
| Minority Interest | -0.06 | - | - | - | - | Upgrade
|
| Shareholders' Equity | -1.55 | 7.95 | 0.41 | 4.8 | 25.54 | Upgrade
|
| Total Liabilities & Equity | 25.15 | 15.28 | 10.73 | 13.72 | 33.69 | Upgrade
|
| Total Debt | 13.5 | 1.51 | 2 | 2.41 | 1.27 | Upgrade
|
| Net Cash (Debt) | -11.47 | 4.75 | -0.35 | 1.11 | 22.77 | Upgrade
|
| Net Cash Growth | - | - | - | -95.14% | 34.58% | Upgrade
|
| Net Cash Per Share | -1.12 | 0.95 | -0.29 | 1.20 | 26.80 | Upgrade
|
| Filing Date Shares Outstanding | 13.49 | 5.89 | 2.73 | 1.19 | 0.92 | Upgrade
|
| Total Common Shares Outstanding | 9.29 | 5.89 | 1.83 | 0.92 | 0.92 | Upgrade
|
| Working Capital | -13.69 | 2.5 | -4.83 | -1.39 | 19.82 | Upgrade
|
| Book Value Per Share | -0.16 | 1.35 | 0.22 | 5.22 | 27.75 | Upgrade
|
| Tangible Book Value | -14.11 | 4.7 | -2.85 | 1.66 | 22.36 | Upgrade
|
| Tangible Book Value Per Share | -1.52 | 0.80 | -1.56 | 1.80 | 24.29 | Upgrade
|
| Machinery | 3.5 | 1.76 | 1.73 | 1.41 | 1.47 | Upgrade
|
| Construction In Progress | - | 1.86 | 1.44 | 0.95 | 0.21 | Upgrade
|
| Leasehold Improvements | 3.2 | 2.48 | 2.48 | 2.48 | 2.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.